An innovative new asthma test is set to dramatically improve treatment for millions of people living with asthma.

Exhaled NO testing -- discovered and developed by leading scientists at Aerocrine -- measures inflammation in the airways which is the underlying cause of asthma. In fact, it tests for a specific type of inflammation that doctors know responds the best to, or is best controlled by, a certain type of medication.

So people with asthma are more likely to get the best treatment.